Managing noradrenaline after traumatic brain injury

Rashad Hussain; Maiken Nedergaard

doi:10.1002/ctm2.1562

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (1) : e1562 DOI: 10.1002/ctm2.1562

COMMENTARY

Managing noradrenaline after traumatic brain injury

Rashad Hussain ¹^,^†
, Maiken Nedergaard ¹^,²^,^†

Author information +

History +

PDF

Cite this article

Download citation ▾

Rashad Hussain, Maiken Nedergaard. Managing noradrenaline after traumatic brain injury. Clinical and Translational Medicine, 2024, 14(1): e1562 DOI:10.1002/ctm2.1562

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Hamill RW, Woolf PD, McDonald JV, Lee LA, Kelly M. Catecholamines predict outcome in traumatic brain injury. Ann Neurol. 1987;21:438-443.

[2]	Rizoli SB, Jaja BNR, Di Battista AP, et al. Catecholamines as outcome markers in isolated traumatic brain injury: the COMA-TBI study. Crit Care. 2017;21(1):37.

[3]	Hussain R, Tithof J, Wang W, et al. Potentiating glymphatic drainage minimizes post-traumatic cerebral oedema. Nature. 2023;623:992-1000.

[4]	Da Mesquita S, Louveau A, Vaccari A, et al. Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease. Nature. 2018;560(7717):185-191.

[5]	Wang L, Zhang Y, Zhao Y, et al. Deep cervical lymph node ligation aggravates AD-like pathology of APP/PS1 mice. Brain Pathol. 2019;29(2):176-192.

[6]	Gregory T, Smith M. Cardiovascular complications of brain injury. Contin Educ Anaesth Crit Care Pain. 2011;12:67-71.

[7]	Lloyd-Donald P, Spencer W, Cheng J, et al. In adult patients with severe traumatic brain injury, does the use of norepinephrine for augmenting cerebral perfusion pressure improve neurological outcome? Injury. 2020;51(10):2129-2134.

[8]	Meyfroidt G, Baguley IJ, Menon DK. Paroxysmal sympathetic hyperactivity: the storm after acute brain injury. Lancet Neurol. 2017;16:721-729.

[9]	Stover JF, Sakowitz OW, Schöning B, et al. Norepinephrine infusion increases interleukin-6 in plasma and cerebrospinal fluid of brain-injured rats. Med Sci Monit. 2003;9:Br382-Br388.

[10]	Udy A, Boots R, Senthuran S, et al. Augmented creatinine clearance in traumatic brain injury. Anesth Analg. 2010;111(6):1505-1510.

[11]	Tschuor C, Asmis LM, Lenzlinger PM, et al. In vitro norepinephrine significantly activates isolated platelets from healthy volunteers and critically ill patients following severe traumatic brain injury. Crit Care. 2008;12(3):R80.

[12]	Ding H, Liao L, Zheng X, et al. β-Blockers for traumatic brain injury: a systematic review and meta-analysis. J Trauma Acute Care Surg. 2021;90(6):1077-1085.

[13]	Mayer CL, Savage PJ, Engle CK, et al. Randomized controlled pilot trial of prazosin for prophylaxis of posttraumatic headaches in active-duty service members and veterans. Headache. 2023;63(6):751-762.

[14]	George KC, Kebejian L, Ruth LJ, Miller CW, Himelhoch S. Meta-analysis of the efficacy and safety of prazosin versus placebo for the treatment of nightmares and sleep disturbances in adults with posttraumatic stress disorder. J Trauma Dissociation. 2016;17:494-510.

[15]	Nissinen J, Andrade P, Natunen T, et al. Disease-modifying effect of atipamezole in a model of post-traumatic epilepsy. Epilepsy Res. 2017;136:18-34.

RIGHTS & PERMISSIONS

2024 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.